324
Views
5
CrossRef citations to date
0
Altmetric
REVIEW

Current Perspectives on the Impact of Chronic Migraine on Sleep Quality: A Literature Review

ORCID Icon, ORCID Icon & ORCID Icon
Pages 1783-1800 | Received 02 Apr 2022, Accepted 09 Sep 2022, Published online: 06 Oct 2022

References

  • Pescador Ruschel MA, De Jesus O. Migraine headache. In: StatPearls. Treasure Island (FL): StatPearls Publishing Copyright © 2022, StatPearls Publishing LLC; 2022.
  • Stovner LJ, Nichols E, Steiner TJet al. Global, regional, and national burden of migraine and tension-type headache, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol. 2018;17:954–976. doi:10.1016/S1474-4422(18)30322-3
  • Huntsman DD, Bulaj G. Healthy dwelling: design of biophilic interior environments fostering self-care practices for people living with migraines, chronic pain, and depression. Int J Environ Res Public Health. 2022;19(4):2248. doi:10.3390/ijerph19042248
  • Hutka P, Krivosova M, Muchova Z, et al. Association of sleep architecture and physiology with depressive disorder and antidepressants treatment. Int J Mol Sci. 2021;22:1333. doi:10.3390/ijms22031333
  • Maurovich-Horvat E, Pollmacher T, Sonka K. The effects of sleep and sleep deprivation on metabolic, endocrine and immune parameters. Prague Med Rep. 2008;109:275–285.
  • Waliszewska-Prosół M, Nowakowska-Kotas M, Chojdak-łukasiewicz J, Budrewicz S. Migraine and sleep—an unexplained association? Int J Mol Sci. 2021;22:5539. doi:10.3390/ijms22115539
  • Potter GD, Skene DJ, Arendt J, Cade JE, Grant PJ, Hardie LJ. Circadian rhythm and sleep disruption: causes, metabolic consequences, and countermeasures. Endocr Rev. 2016;37:584–608. doi:10.1210/er.2016-1083
  • Kelman L. The triggers or precipitants of the acute migraine attack. Cephalalgia. 2007;27:394–402. doi:10.1111/j.1468-2982.2007.01303.x
  • Goadsby PJ, Holland PR, Martins-Oliveira M, Hoffmann J, Schankin C, Akerman S. Pathophysiology of migraine: a disorder of sensory processing. Physiol Rev. 2017;97(2):553–622. doi:10.1152/physrev.00034.2015
  • Rains JC, Poceta JS, Penzien DB. Sleep and headaches. Curr Neurol Neurosci Rep. 2008;8(2):167–175. doi:10.1007/s11910-008-0027-9
  • Vgontzas A, Pavlović JM. Sleep disorders and migraine: review of literature and potential pathophysiology mechanisms. Headache. 2018;58:1030–1039. doi:10.1111/head.13358
  • Lin YK, Lin GY, Lee JT, et al. Associations between sleep quality and migraine frequency: a cross-sectional case-control study. Medicine. 2016;95:e3554. doi:10.1097/MD.0000000000003554
  • Altamura C, Corbelli I, de Tommaso M, et al. Pathophysiological bases of comorbidity in migraine. Front Hum Neurosci. 2021;15:640574. doi:10.3389/fnhum.2021.640574
  • Arendt‐Nielsen L, Morlion B, Perrot S, et al. Assessment and manifestation of central sensitisation across different chronic pain conditions. Eur J Pain. 2018;22:216–241. doi:10.1002/ejp.1140
  • Krause AJ, Prather AA, Wager TD, Lindquist MA, Walker MP. The pain of sleep loss: a brain characterization in humans. J Neurosci. 2019;39:2291–2300. doi:10.1523/JNEUROSCI.2408-18.2018
  • Buse DC, Greisman JD, Baigi K, Lipton RB. Migraine progression: a systematic review. Headache. 2019;59:306–338. doi:10.1111/head.13459
  • Duman T, Dede Ö, Uluduz H, Seydaoğlu D, Okuyucu G, Melek İ. Sleep changes during prophylactic treatment of migraine. Ann Indian Acad Neurol. 2015;18:298–302. doi:10.4103/0972-2327.160084
  • Buse DC, Rains JC, Pavlovic JM, et al. Sleep disorders among people with migraine: results from the chronic migraine epidemiology and outcomes (CaMEO) study. Headache. 2019;59:32–45. doi:10.1111/head.13435
  • Kim J, Cho SJ, Kim WJ, Yang KI, Yun CH, Chu MK. Insufficient sleep is prevalent among migraineurs: a population-based study. J Headache Pain. 2017;18:50. doi:10.1186/s10194-017-0756-8
  • Wöber C, Wöber-Bingöl C. Triggers of migraine and tension-type headache. Handb Clin Neurol. 2010;97:161–172.
  • Sandoe CH, Sasikumar S, Lay C, Lawler V. The impact of shift work on migraine: a case series and narrative review. Headache. 2019;59(9):1631–1640. doi:10.1111/head.13622
  • Kelman L, Rains JC. Headache and sleep: examination of sleep patterns and complaints in a large clinical sample of migraineurs. Headache. 2005;45:904–910. doi:10.1111/j.1526-4610.2005.05159.x
  • Sullivan DP, Martin PR, Boschen MJ. Psychological sleep interventions for migraine and tension-type headache: a systematic review and meta-analysis. Sci Rep. 2019;9:6411. doi:10.1038/s41598-019-42785-8
  • Giffin N, Ruggiero L, Lipton RB, et al. Premonitory symptoms in migraine: an electronic diary study. Neurology. 2003;60:935–940. doi:10.1212/01.WNL.0000052998.58526.A9
  • Giffin NJ, Lipton RB, Silberstein SD, Olesen J, Goadsby PJ. The migraine postdrome: an electronic diary study. Neurology. 2016;87:309–313. doi:10.1212/WNL.0000000000002789
  • Adams AM, Serrano D, Buse DC, et al. The impact of chronic migraine: the Chronic Migraine Epidemiology and Outcomes (CaMEO) Study methods and baseline results. Cephalalgia. 2015;35:563–578. doi:10.1177/0333102414552532
  • Smith MT, Edwards RR, McCann UD, Haythornthwaite JA. The effects of sleep deprivation on pain inhibition and spontaneous pain in women. Sleep. 2007;30:494–505. doi:10.1093/sleep/30.4.494
  • Moreno-Ajona D, Villar-Martínez MD, Goadsby PJ. Emerging targets for migraine treatment. Neurol India. 2021;69(7):S98–s104. doi:10.4103/0028-3886.315989
  • Androulakis XM, Krebs KA, Jenkins C, et al. Central executive and default mode network intranet work functional connectivity patterns in chronic migraine. J Neurol Disord. 2018;6. doi:10.4172/2329-6895.1000393
  • Woldeamanuel YW, DeSouza DD, Sanjanwala BM, Cowan RP. Clinical features contributing to cortical thickness changes in chronic migraine–a pilot study. Headache. 2019;59:180–191. doi:10.1111/head.13452
  • Neeb L, Bastian K, Villringer K, Israel H, Reuter U, Fiebach JB. Structural gray matter alterations in chronic migraine: implications for a progressive disease? Headache. 2017;57(3):400–416. doi:10.1111/head.13012
  • Schulte LH, Allers A, May A. Hypothalamus as a mediator of chronic migraine: evidence from high-resolution fMRI. Neurology. 2017;88(21):2011–2016. doi:10.1212/WNL.0000000000003963
  • Utiumi MAT, Küster JGB, Godk KS, et al. Prevalence of trigeminocervical convergence mechanisms in episodic and chronic migraine. Arq Neuropsiquiatr. 2022;80(5):482–489. doi:10.1590/0004-282x-anp-2021-0095
  • Tsai C-K, Tsai C-L, Lin G-Y, Yang F-C, Wang S-J. Sex differences in chronic migraine: focusing on clinical features, pathophysiology, and treatments. Curr Pain Headache Rep. 2022;26:1–9.
  • Filipchuk M, Gassmann J, Castro Zamparella T, et al. High rates of (treated) hypothyroidism among chronic migraine patients consulting a specialized headache clinic: are we missing something? Neurol Sci. 2022;43(2):1249–1254. doi:10.1007/s10072-021-05424-7
  • Andreou AP, Edvinsson L. Mechanisms of migraine as a chronic evolutive condition. J Headache Pain. 2019;20:117. doi:10.1186/s10194-019-1066-0
  • Mollaoğlu M. Trigger factors in migraine patients. J Health Psychol. 2013;18:984–994. doi:10.1177/1359105312446773
  • Grozeva V, Mínguez-Olaondo A, Vila-Pueyo M. Experiment in vivo: how COVID-19 lifestyle modifications affect migraine. Front Neurol. 2021;12:744796. doi:10.3389/fneur.2021.744796
  • Bigal ME, Lipton RB. What predicts the change from episodic to chronic migraine? Curr Opin Neurol. 2009;22:269–276. doi:10.1097/WCO.0b013e32832b2387
  • Frampton JE, Silberstein S. OnabotulinumtoxinA: a review in the prevention of chronic migraine. Drugs. 2018;78:589–600. doi:10.1007/s40265-018-0894-6
  • Yin JH, Lin YK. Prevalence and association of lifestyle and medical-, psychiatric-, and pain-related comorbidities in patients with migraineA Cross-Sectional Study. Headache. 2021;61:715–726.
  • Scher AI, Bigal ME, Lipton RB. Comorbidity of migraine. Curr Opin Neurol. 2005;18:305–310. doi:10.1097/01.wco.0000169750.52406.a2
  • Lin Y-K, Lin G-Y, Lee J-T, et al. Associations between sleep quality and migraine frequency: a cross-sectional case-control study. Medicine. 2016;95:e3554.
  • Yang CP, Wang SJ. Sleep in patients with chronic migraine. Curr Pain Headache Rep. 2017;21:39. doi:10.1007/s11916-017-0641-9
  • Ong JC, Park M. Chronic headaches and insomnia: working toward a biobehavioral model. Cephalalgia. 2012;32(14):1059–1070. doi:10.1177/0333102412455709
  • Lin GY, Lin YK, Lee JT, et al. Prevalence of restless legs syndrome in migraine patients with and without aura: a cross-sectional, case-controlled study. J Headache Pain. 2016;17:97. doi:10.1186/s10194-016-0691-0
  • Barbanti P, Aurilia C, Egeo G, Fofi L, Vanacore N. A case-control study on excessive daytime sleepiness in chronic migraine. Sleep Med. 2013;14:278–281. doi:10.1016/j.sleep.2012.10.022
  • Maizels M, Burchette R. Somatic symptoms in headache patients: the influence of headache diagnosis, frequency, and comorbidity. Headache. 2004;44(10):983–993. doi:10.1111/j.1526-4610.2004.04192.x
  • Viana M, Bottiroli S, Sances G, et al. Factors associated to chronic migraine with medication overuse: a cross-sectional study. Cephalalgia. 2018;38:2045–2057. doi:10.1177/0333102418761047
  • Lucchesi C, Baldacci F, Cafalli M, et al. Fatigue, sleep-wake pattern, depressive and anxiety symptoms and body-mass index: analysis in a sample of episodic and chronic migraine patients. Neurol Sci. 2016;37:987–989. doi:10.1007/s10072-016-2505-1
  • Ceylan M, Yalcin A. Coexistence of symptoms associated with trigeminal pathways in chronic and episodic migraine and the effects on quality of life. Pain Med. 2019;20:172–179. doi:10.1093/pm/pny118
  • Lucchesi C, Bonanni E, Maestri M, Siciliano G, Murri L, Gori S. Evidence of increased restless legs syndrome occurrence in chronic and highly disabling migraine. Funct Neurol. 2012;27:91–94.
  • de Tommaso M, Delussi M, Vecchio E, Sciruicchio V, Invitto S, Livrea P. Sleep features and central sensitization symptoms in primary headache patients. J Headache Pain. 2014;15:64. doi:10.1186/1129-2377-15-64
  • Andress-Rothrock D, King W, Rothrock J. An analysis of migraine triggers in a clinic-based population. Headache. 2010;50:1366–1370. doi:10.1111/j.1526-4610.2010.01753.x
  • Calhoun AH, Ford S, Finkel AG, Kahn KA, Mann JD. The prevalence and spectrum of sleep problems in women with transformed migraine. Headache. 2006;46:604–610. doi:10.1111/j.1526-4610.2006.00410.x
  • Kim SH, Park JY, Shin HE, Ryu DW, Kim TW, Park JW. The influence of rapid eye movement sleep deprivation on nociceptive transmission and the duration of facial allodynia in rats: a behavioral and Fos immunohistochemical study. J Headache Pain. 2019;20:1–9. doi:10.1186/s10194-019-0977-0
  • de Tommaso M, Delussi M. Circadian rhythms of migraine attacks in episodic and chronic patients: a cross sectional study in a headache center population. BMC Neurol. 2018;18:94. doi:10.1186/s12883-018-1098-0
  • van Oosterhout W, van Someren E, Schoonman GG, et al. Chronotypes and circadian timing in migraine. Cephalalgia. 2018;38:617–625. doi:10.1177/0333102417698953
  • Burish MJ, Chen Z. Emerging relevance of circadian rhythms in headaches and neuropathic pain. Acta Physiologica. 2019;225:e13161. doi:10.1111/apha.13161
  • Junker U, Wirz S. Review article: chronobiology: influence of circadian rhythms on the therapy of severe pain. J Oncol Pharm Pract. 2010;16(2):81–87. doi:10.1177/1078155209337665
  • Packard A, Smotherman C. Effect of circadian rhythm on the pain associated with preventive onabotulinumtoxinA injections for migraines. Chronobiol Int. 2020;37:1766–1771. doi:10.1080/07420528.2020.1802290
  • Ong JC, Taylor HL, Park M, et al. Can circadian dysregulation exacerbate migraines? Headache. 2018;58:1040–1051. doi:10.1111/head.13310
  • Peres MF, Sanchez Del Rio M, Seabra ML, et al. Hypothalamic involvement in chronic migraine. J Neurol Neurosurg Psychiatry. 2001;71:747–751. doi:10.1136/jnnp.71.6.747
  • Pandi-Perumal SR, Cardinali DP, Zaki NF, et al. Timing is everything: circadian rhythms and their role in the control of sleep. Front Neuroendocrinol. 2022;100978. doi:10.1016/j.yfrne.2022.100978
  • Fonken LK, Frank MG, Kitt MM, Barrientos RM, Watkins LR, Maier SF. Microglia inflammatory responses are controlled by an intrinsic circadian clock. Brain Behav Immun. 2015;45:171–179. doi:10.1016/j.bbi.2014.11.009
  • Buse DC, Fanning KM, Reed ML, et al. Life with migraine: effects on relationships, career, and finances from the Chronic Migraine Epidemiology and Outcomes (CaMEO) Study. Headache. 2019;59:1286–1299. doi:10.1111/head.13613
  • Garrigós-Pedrón M, Segura-Ortí E, Gracia-Naya M, La Touche R. Predictive factors of sleep quality in patients with chronic migraine. Neurologia. 2022;37:101–109. doi:10.1016/j.nrl.2018.11.004
  • Di Stefano V, Ornello R. Social distancing in chronic migraine during the COVID-19 Outbreak: results from a multicenter observational study. Nutrients. 2021;13:1361. doi:10.3390/nu13041361
  • Currò CT, Ciacciarelli A, Vitale C, et al. Chronic migraine in the first COVID-19 lockdown: the impact of sleep, remote working, and other life/psychological changes. Neurol Sci. 2021;42:4403–4418. doi:10.1007/s10072-021-05521-7
  • Gardani M, Bradford DRR, Russell K, et al. A systematic review and meta-analysis of poor sleep, insomnia symptoms and stress in undergraduate students. Sleep Med Rev. 2022;61:101565. doi:10.1016/j.smrv.2021.101565
  • Scher AI, Midgette LA, Lipton RB. Risk factors for headache chronification. Headache. 2008;48:16–25. doi:10.1111/j.1526-4610.2007.00970.x
  • Huang Y, Zhao N. Generalized anxiety disorder, depressive symptoms and sleep quality during COVID-19 outbreak in China: a web-based cross-sectional survey. Psychiatry Res. 2020;288:112954. doi:10.1016/j.psychres.2020.112954
  • Bertisch SM, Li W. Nightly sleep duration, fragmentation, and quality and daily risk of migraine. Neurology. 2020;94:e489–e496. doi:10.1212/WNL.0000000000008740
  • Rains JC. Sleep and migraine: assessment and treatment of comorbid sleep disorders. Headache. 2018;58:1074–1091. doi:10.1111/head.13357
  • Ødegård SS, Sand T, Engstrøm M, Zwart JA, Hagen K. The impact of headache and chronic musculoskeletal complaints on the risk of insomnia: longitudinal data from the Nord-Trøndelag health study. J Headache Pain. 2013;14:24. doi:10.1186/1129-2377-14-24
  • Guieu R, Devaux C, Henry H, et al. Adenosine and migraine. Can J Neurol Sci. 1998;25:55–58.
  • Lindquist BE, Shuttleworth CW. Adenosine receptor activation is responsible for prolonged depression of synaptic transmission after spreading depolarization in brain slices. Neuroscience. 2012;223:365–376. doi:10.1016/j.neuroscience.2012.07.053
  • Lindquist BE, Shuttleworth CW. Evidence that adenosine contributes to Leao’s spreading depression in vivo. J Cereb Blood Flow Metab. 2017;37:1656–1669. doi:10.1177/0271678X16650696
  • Stanyer EC, Creeney H, Nesbitt AD, Holland PR. Subjective sleep quality and sleep architecture in patients with migraine. A Meta-Analysis. 2021;97:e1620–e1631.
  • Feng H, Wen SY, Qiao QC, et al. Orexin signaling modulates synchronized excitation in the sublaterodorsal tegmental nucleus to stabilize REM sleep. Nat Commun. 2020;11:3661. doi:10.1038/s41467-020-17401-3
  • Villalón CM, Olesen J. The role of CGRP in the pathophysiology of migraine and efficacy of CGRP receptor antagonists as acute antimigraine drugs. Pharmacol Ther. 2009;124:309–323. doi:10.1016/j.pharmthera.2009.09.003
  • Kunst M, Hughes ME, Raccuglia D, et al. Calcitonin gene-related peptide neurons mediate sleep-specific circadian output in Drosophila. Curr Biol. 2014;24:2652–2664. doi:10.1016/j.cub.2014.09.077
  • Lőrincz ML, Adamantidis AR. Monoaminergic control of brain states and sensory processing: existing knowledge and recent insights obtained with optogenetics. Prog Neurobiol. 2017;151:237–253. doi:10.1016/j.pneurobio.2016.09.003
  • Chen XY, Chen ZY, Dong Z, Liu MQ, Yu SY. Regional volume changes of the brain in migraine chronification. Neural Regenera Res. 2020;15:1701–1708. doi:10.4103/1673-5374.276360
  • Younis S, Hougaard A, Noseda R, Ashina M. Current understanding of thalamic structure and function in migraine. Cephalalgia. 2019;39(13):1675–1682. doi:10.1177/0333102418791595
  • Smelt AF, Louter MA, Kies DA, et al. What do patients consider to be the most important outcomes for effectiveness studies on migraine treatment? Results of a Delphi study. PLoS One. 2014;9:e98933. doi:10.1371/journal.pone.0098933
  • De Icco R, Putortì A, De Paoli I, et al. Anodal transcranial direct current stimulation in chronic migraine and medication overuse headache: a pilot double-blind randomized sham-controlled trial. Clin Neurophysiol. 2021;132:126–136. doi:10.1016/j.clinph.2020.10.014
  • Ulusoy EK, Bolattürk ÖF. The effect of greater occipital nerve blockade on the quality of life, disability and comorbid depression, anxiety, and sleep disturbance in patients with chronic migraine. Neurol Sci. 2020;41:1829–1835. doi:10.1007/s10072-020-04286-9
  • Saçmacı H, Aktürk T, Tanık N, İnan LE. Clinical success of greater occipital nerve blockade in improving sleep quality of chronic migraineurs: a prospective observational study. Sleep Breath Schlaf Atmung. 2021;25:1003–1010. doi:10.1007/s11325-021-02309-z
  • Smitherman TA, Walters AB, Davis RE, et al. Randomized controlled pilot trial of behavioral insomnia treatment for chronic migraine with comorbid insomnia. Headache. 2016;56:276–291. doi:10.1111/head.12760
  • Crawford MR, Luik AI, Espie CA, et al. Digital cognitive behavioral therapy for insomnia in women with chronic migraines. J Headache Pain. 2020;60:902–915. doi:10.1111/head.13777
  • Blumenfeld AM, Tepper SJ, Robbins LD, Manack Adams A, Buse DC, Orejudos A. Effects of onabotulinumtoxinA treatment for chronic migraine on common comorbidities including depression and anxiety. J Neurol Neurosurg Psychiatry. 2019;90:353–360. doi:10.1136/jnnp-2018-319290
  • Aydinlar EI, Dikmen PY, Kosak S, Kocaman AS. OnabotulinumtoxinA effectiveness on chronic migraine, negative emotional states and sleep quality: a single-center prospective cohort study. J Headache Pain. 2017;18:23. doi:10.1186/s10194-017-0723-4
  • Loeb LM, Amorim RP, Mazzacoratti M, Scorza FA, Peres MFP. Botulinum toxin A (BT-A) versus low-level laser therapy (LLLT) in chronic migraine treatment: a comparison. Arq Neuropsiquiatr. 2018;76:663–667. doi:10.1590/0004-282x20180109
  • Barad M, Sturgeon JA, Fish S, Dexter F, Mackey S, Flood PD. Response to BotulinumtoxinA in a migraine cohort with multiple comorbidities and widespread pain. Reg Anesth Pain Med. 2019;44:660–668. doi:10.1136/rapm-2018-100196
  • Cernuda-Morollón E, Ramón C, Martínez-Camblor P, Serrano-Pertierra E, Larrosa D, Pascual J. OnabotulinumtoxinA decreases interictal CGRP plasma levels in patients with chronic migraine. Pain. 2015;156:820–824. doi:10.1097/j.pain.0000000000000119
  • Rodrigo D, Acin P, Bermejo P. Occipital nerve stimulation for refractory chronic migraine: results of a long-term prospective study. Pain Physician. 2017;20:E151–E159. doi:10.36076/2017.1.E151
  • Kinfe TM, Pintea B, Muhammad S, et al. Cervical non-invasive vagus nerve stimulation (nVNS) for preventive and acute treatment of episodic and chronic migraine and migraine-associated sleep disturbance: a prospective observational cohort study. J Headache Pain. 2015;16:101. doi:10.1186/s10194-015-0582-9
  • Peres MF, Mercante JP, Tanuri FC, Nunes M, Zukerman E. Chronic migraine prevention with topiramate. J Headache Pain. 2006;7:185–187. doi:10.1007/s10194-006-0339-6
  • Saper JR, Lake AE, Tepper SJ. Nefazodone for chronic daily headache prophylaxis: an open-label study. Headache. 2001;41:465–474. doi:10.1046/j.1526-4610.2001.01084.x
  • Russo A, Silvestro M, Scotto Di Clemente F, et al. Multidimensional assessment of the effects of erenumab in chronic migraine patients with previous unsuccessful preventive treatments: a comprehensive real-world experience. J Headache Pain. 2020;21:69. doi:10.1186/s10194-020-01143-0
  • Tiseo C, Vacca A, Felbush A, et al. Migraine and sleep disorders: a systematic review. J Headache Pain. 2020;21:126. doi:10.1186/s10194-020-01192-5